| 2024 | 2023 | 2022 | 2021 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 234,0 k € | -1.4% | 237,3 k € | -25.1% | 316,8 k € | -26.4% | 430,7 k € | +61.3% | 267,1 k € | -3.3% | 276,1 k € | +15.6% | 238,7 k € | +10.4% | 216,2 k € | +6.0% | 203,9 k € | -5.5% | 215,9 k € | +19.4% | 180,8 k € | +2.0% | 177,3 k € | |
| EBITDA | 177,3 k € | -0.3% | 177,8 k € | -30.5% | 255,8 k € | -32.0% | 376,1 k € | +47.5% | 254,9 k € | -6.3% | 272,1 k € | +26.2% | 215,5 k € | -0.1% | 215,7 k € | +6.0% | 203,4 k € | -5.6% | 215,5 k € | +19.6% | 180,2 k € | +1.7% | 177,2 k € | |
| Operating profit | 174,3 k € | +7.3% | 162,5 k € | -29.3% | 229,7 k € | -34.1% | 348,6 k € | +55.2% | 224,6 k € | -6.2% | 239,4 k € | +29.5% | 184,9 k € | +0.2% | 184,5 k € | +11.0% | 166,2 k € | -7.4% | 179,4 k € | +38.7% | 129,3 k € | +18.0% | 109,6 k € | |
| Profit/loss | 134,3 k € | +2.0% | 131,7 k € | -18.0% | 160,7 k € | -34.4% | 244,8 k € | +68.6% | 145,2 k € | -17.6% | 176,3 k € | +60.0% | 110,2 k € | -0.2% | 110,4 k € | +14.3% | 96,6 k € | -4.5% | 101,2 k € | +39.5% | 72,5 k € | +28.0% | 56,6 k € | |
| Equity | 312,4 k € | 0.0% | 312,4 k € | -68.1% | 980,2 k € | +19.6% | 819,5 k € | -19.1% | 1,0 M € | +7.5% | 942,2 k € | +23.0% | 765,9 k € | +16.8% | 655,8 k € | +20.2% | 545,3 k € | +21.5% | 448,8 k € | +12.9% | 397,6 k € | +22.3% | 325,1 k € | |
| Total assets | 732,6 k € | +21.6% | 602,4 k € | -42.4% | 1,0 M € | +1.0% | 1,0 M € | -3.0% | 1,1 M € | -5.4% | 1,1 M € | +17.0% | 964,8 k € | +8.9% | 886,3 k € | +9.4% | 810,0 k € | +2.3% | 792,0 k € | +7.8% | 734,8 k € | +8.9% | 675,0 k € | |
| Cash | 146,0 k € | -58.7% | 353,6 k € | -59.0% | 862,5 k € | +410.6% | 168,9 k € | -69.7% | 556,9 k € | -8.1% | 605,9 k € | +243.0% | 176,6 k € | -41.4% | 301,6 k € | +91.5% | 157,5 k € | +26.2% | 124,8 k € | -54.8% | 275,9 k € | +56.4% | 176,5 k € | |
| Debts | 400,7 k € | +38.6% | 289,1 k € | +356.6% | 63,3 k € | -69.6% | 208,4 k € | +286.9% | 53,9 k € | -70.9% | 185,3 k € | -6.8% | 198,9 k € | -13.4% | 229,7 k € | -13.1% | 264,1 k € | -23.0% | 343,2 k € | +2.1% | 336,2 k € | -3.7% | 349,0 k € | |
| Staff | 1 | 1 | 1 | 1 | 0,5 | 0,1 | — | — | — | — | — | — | ||||||||||||
Private limited company · Antwerpen · incorporated on 27/06/1997 · 1,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-58.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK ELSDONK is a Private limited company incorporated in 1997. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 1,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette